Cite
The potential of circHIPK3 as a biomarker in chronic myeloid leukemia.
MLA
Wandame Gomez, Eduardo, et al. “The Potential of CircHIPK3 as a Biomarker in Chronic Myeloid Leukemia.” Frontiers in Oncology, Mar. 2024, pp. 1–7. EBSCOhost, https://doi.org/10.3389/fonc.2024.1330592.
APA
Wandame Gomez, E., Berti De Paula, L., Diogo Weimer, R., da Silva Hellwig, A. H., Motta Rodrigues, G., Paula Alegretti, A., & Rodrigues de Oliveira, J. (2024). The potential of circHIPK3 as a biomarker in chronic myeloid leukemia. Frontiers in Oncology, 1–7. https://doi.org/10.3389/fonc.2024.1330592
Chicago
Wandame Gomez, Eduardo, Laura Berti De Paula, Rafael Diogo Weimer, Alessandra Helena da Silva Hellwig, Grazielle Motta Rodrigues, Ana Paula Alegretti, and Jarbas Rodrigues de Oliveira. 2024. “The Potential of CircHIPK3 as a Biomarker in Chronic Myeloid Leukemia.” Frontiers in Oncology, March, 1–7. doi:10.3389/fonc.2024.1330592.